Estrogen replacement therapy and frontotemporal dementia

Maturitas

Volumn 45, Issue 2, 2003, Pages 83-88

  Levine, Andrew J ^a   Hewett, Linda ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dementia; Estrogen replacement; Frontotemporal

Indexed keywords

ESTROGEN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN THERAPY; FEMALE; FRONTOTEMPORAL DEMENTIA; HEALTH SURVEY; HUMAN; RISK FACTOR; CASE CONTROL STUDY; DEMENTIA; MIDDLE AGED; PATHOLOGY; UNITED STATES; UTILIZATION REVIEW;

AGED; CALIFORNIA; CASE-CONTROL STUDIES; DEMENTIA; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED;

EID: 0142093971     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(03)00142-7     Document Type: Article

References (29)

1. Brinton R.D., Yamazaki R.S. Advances and challenges in the prevention and treatment of Alzheimer's disease. Pharmaceutical Research. 15:(3):1998;386-398.
2. Monk D., Brodaty H. Use of estrogens for the prevention and treatment of Alzheimer's disease. Dementia and the Geriatric Cognitive Disorders. 11:2000;1-10.
3. Jorm A.F., Korten A.E., Henderson A.S. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatrica Scandinavica. 76:(5):1987;465-479.
4. Brinton R.D., Tran J., Profitt P., Kahil M. 17 Beta-estradiol increases the growth and survival of cultured cortical neurons. Neurochemical Research. 22:1997;1339-1351.
5. Gould E., Woolley C.S., Frankfurt M., McEwen B.S. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. The Journal of Neuroscience. 10:(4):1990;1286-1291.
6. Luine V.N. Estradiol increases acetyltransferase activity in specific basal forebrain nuclei and projection areas of the female rat brain. Experimental Neurology. 89:1985;484-490.
7. Rabbani O., Panickar K.S., Rajakumar G., King M.A., Bodar N., Meyer E., Simpkins J. 17 Beta-estradiol attenuates fimbrial lesion-induced decline of ChAT-immunoreactive neurons in the rat medial septum. Experimental Neurology. 146:1997;179-186.
8. Behl C., Skutella T., Lezoualc'h F., Post A., Widmann M., Newton C.J. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Molecular Pharmacology. 51:1997;535-541.
9. Pike C.J. Estrogen modulates neuronal Bcl-XL expression and beta-amyloid-induced apoptosis: Relevance to Alzheimer's disease. Journal of Neurochemistry. 72:1999;1552-1563.
10. Neary D., Snowden J.S., Mann D.M.A. Classification and description of frontotemporal dementias. Annals of the New York Academy of Sciences. 920:2000;46-51.
11. Neary D., Snowden J.S., Gustafson L., Passant U., Stuss D., Black S., et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 51:1998;1546-1554.
12. The Lund and Manchester Groups. Consensus statement. Clinical and neuropathological criteria for frontotemporal dementia, Journal of Neurology Neurosurgery and Psychiatry 1994;57(4):416-8.
13. Giasson B.I., Wilson C.A., Trojanowski J.Q., Lee V.M.-Y. Tau and alpha-synuclein dysfunction in neurodegenerative diseases. Chesselet M.-F., Totowa N.J. Contemporary clinical neuroscience: molecular mechanisms of neurodegenerative diseases. 2000;151-176 Humana Press.
14. Wilhelmsen K.C., Clark L.N., Miller B.L., Geschwind D.H. Tau mutations in frontotemporal dementia. Dementia and Geriatric Cognitive Disorders. 10:(1):1999;88-92.
15. Groenveld F.P.M.J., Boreman F.P., Barensten R., Dokter H.J., Drogendijk A.C., Hoes A.W. Determinants of first prescription of hormone replacement therapy. A follow-up study among 1689 women aged 45-60 years. Maturitas. 20:1995;81-89.
16. McNagny S. Personal use of postmenopausal hormone replacement therapy by women physicians in the United States. Annals of Internal Medicine. 127:1997;1093-1096.
17. Harris R., Laws A., Reddy V., King A., Haskell W. Are women using postmenopausal estrogens: a community survey. American Journal of Public Health. 80:1990;1266-1268.
18. Johannes C., Crawford S., Posner J., Mckinlay S. Longitudinal patterns and correlates of hormone replacement therapy use in middle aged women. American Journal of Epidemiology. 140:1994;439-452.
19. Falik M., Collins K. Women's health; the commonwealth fund study. 1996;Johns Hopkins Press, Baltimore.
20. Duara R., Barker W., Luis C.A. Frontotemporal dementia and Alzheimer's disease: differential diagnosis. Dementia and Geriatric Cognitive Disorders. 10:(1):1999;37-42.
21. Varma A.R., Snowden J.S., Lloyd J.J., Talbot P.R., Mann D.M., Neary D. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. Journal of Neurology Neurosurgery and Psychiatry. 66:(2):1999;184-188.
22. Tierney M.C., Fisher R.H., Lewis A.J., Zorzitto M.L., Snow W.G., Reid D.W. The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathological study of 57 cases. Neurology. 38:1988;359-364.
23. Sherwin B.B., Gelfand M.M. Sex steroids and effect in the surgical menopause: a double-blind, cross-over study. Psychoneuroendocrinology. 10:1985;325-335.
24. Smith R.N.J., Studd J.W.W. Estrogens and depression in women. Lobo R. Treatment of the postmenopausal woman: basic and clinical aspects. 1994;Raven Press, New York.
25. Zweifel J.E., O'Brien W.H. A meta-analysis of the effects of hormone replacement therapy upon depressed mood. Psychoneuroednocrinology. 22:(3):1997;189-212.
26. Lynch T., Sano M., Marder K.S., Bell K.L., Foster N.L., Defendini R.F. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology. 44:(10):1994;1878-1884.
27. Spillantini M.G., Bird T.D., Ghetti B. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathology. 8:(2):1998;387-402.
28. Hardy J. Pathways to primary neurodegenerative disease. Mayo Clinic Proceedings. 74:1999;835-837.
29. Ferreira A., Caceres A. Estrogen-enhanced neurite growth: evidence for a selective induction of tau and stable microtubules. The Journal of Neuroscience. 11:(2):1991;392-400.